Literature DB >> 4463003

The experimental antitumour properties of three congeners of the acridylmethanesulphonanilide (AMSA) series.

B F Cain, G J Atwell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4463003     DOI： 10.1016/0014-2964(74)90079-6

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  28 in total

1.  Action of SN 28049, a new DNA binding topoisomerase II-directed antitumour drug: comparison with doxorubicin and etoposide.

Authors:  Catherine J Drummond; Graeme J Finlay; Laura Broome; Elaine S Marshall; Emma Richardson; Bruce C Baguley
Journal:  Invest New Drugs       Date:  2010-06-22       Impact factor: 3.850

2.  DNA unwinding and inhibition of mouse leukemia L1210 DNA topoisomerase I by intercalators.

Authors:  Y Pommier; J M Covey; D Kerrigan; J Markovits; R Pham
Journal:  Nucleic Acids Res       Date:  1987-08-25       Impact factor: 16.971

3.  Effectiveness of AMSA alone or in combination with radiation on murine fibrosarcoma pulmonary nodules.

Authors:  D J Grdina; S Jones; N Hunter
Journal:  Clin Exp Metastasis       Date:  1984 Jul-Sep       Impact factor: 5.150

4.  Influence of scheduling on therapeutic and toxic effect of AMSA in Lewis lung carcinoma.

Authors:  C Greco; G Zupi; G Badaracco
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

5.  A phase II study of m-AMSA in patients with malignant mesothelioma.

Authors:  G Falkson; D A Vorobiof; H J Lerner
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

6.  Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide.

Authors:  E M Nelson; K M Tewey; L F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

7.  Novel carbamate analogues of amsacrine with activity against non-cycling murine and human tumour cells.

Authors:  G J Finlay; K M Holdaway; B C Baguley
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

8.  The interaction of ethidium with synthetic double-stranded polynucleotides at low ionic strength.

Authors:  B C Baguley; E M Falkenhaug
Journal:  Nucleic Acids Res       Date:  1978-01       Impact factor: 16.971

9.  m-AMSA and adenocarcinoma of the endometrium. A Southwest Oncology Group study.

Authors:  R D Hilgers; S S Legha; G A Johnston; D S Alberts; R L Stephens; B L Tranum; E V Hannigan
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

10.  Pharmacokinetics of amsacrine in patients receiving combined chemotherapy for treatment of acute myelogenous leukemia.

Authors:  J L Jurlina; A R Varcoe; J W Paxton
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.